Yarapmin Pharma Private Limited
About Yarapmin Pharma Private Limited
Data last updated:
Yarapmin Pharma Private Limited is a private limited company based in Unjha, Gujarat, India. It was incorporated on 03 January 2024.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U46497GJ2024PTC147471.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Yaksh Piyushkumar Patel and Prasanna Nitin Belhekar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.D – 298 New Marketyard, Station Road At &Po – Unjha, Gujarat, India – 384170.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.95 Cr. For the same year it recorded a net profit of ₹60,889 (net margin 0.3%) and EBITDA of ₹19.21 Lakh (EBITDA margin 9.8%).
Company details
Contact details
Yarapmin Pharma Private Limited's registered office is in Unjha, Gujarat.
- Registered AddressNo.D – 298 New Marketyard, Station Road At &Po – Unjha, Gujarat, India – 384170
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yarapmin Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Yarapmin Pharma Private Limited, buy the company report.
Financials of Yarapmin Pharma Private Limited
FY 2025 filings availableYarapmin Pharma Private Limited reported revenue of ₹1.95 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹19.21 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹60,889 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 9.8% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Yarapmin Pharma Private Limited, buy the company report.
Board of directors of Yarapmin Pharma Private Limited
Yarapmin Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yaksh Piyushkumar Patel | Director | 03 Jan 2024 | 2 Years 10 Months | Current |
| Prasanna Nitin Belhekar | Director | 03 Jan 2024 | 2 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Yarapmin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yarapmin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Yarapmin Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Yarapmin Pharma Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Prasanna Nitin Belhekar was appointed as Director on 03 Jan 2024.
Frequently asked questions
Yarapmin Pharma is an active private limited company based in Unjha, Gujarat, India. It was incorporated on 03 January 2024 (2+ years old) and is registered under CIN U46497GJ2024PTC147471.
Yarapmin Pharma has 2 current directors:
- Yaksh Piyushkumar Patel - Director
- Prasanna Nitin Belhekar - Director
The latest financial statements of Yarapmin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Yarapmin Pharma is U46497GJ2024PTC147471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yarapmin Pharma was incorporated on 03 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Prasanna Nitin Belhekar was appointed as Director on 03 Jan 2024. Yaksh Piyushkumar Patel was appointed as Director on 03 Jan 2024.
The registered office of Yarapmin Pharma is at No.D – 298 New Marketyard, Station Road At &Po – Unjha, Gujarat, India – 384170.
Yarapmin Pharma can be reached at its registered office: No.D – 298 New Marketyard, Station Road At &Po – Unjha, Gujarat, India – 384170.
Yarapmin Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
